Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor site version update from v3.4.1 to v3.4.2 with no changes to study content or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedUpdated the location name from Gurgaon, India, 122001 to Gūrgaon, India, 122001 with a diacritic.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page shows a new Revision: v3.3.4 and a deletion of Revision: v3.3.3, indicating a minor site version update with no changes to study content or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a Locations section with multiple sites (Arizona, California, Florida, Georgia, Michigan, New York, Ohio, Tennessee, Texas, Gurgaon, India 122001) and removed the prior state locations; Revision updated to v3.3.3.SummaryDifference0.5%

- Check70 days agoChange DetectedIndia location listing updated: added Gūrgaon, India, 122001 and removed Gurgaon, India, 122001 (diacritic spelling change).SummaryDifference0.0%

- Check91 days agoChange DetectedAdded an explanatory note that PubMed publications are automatically filled from PubMed and may not relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.